drugset / Trial / NCT02438904
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
NaSingle-groupOpen-labelOther
Summary
Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).
Timeline
- Start
- 2015-05-06
- Primary completion
- 2027-05-01
- Completion
- 2027-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD34 Positive Stem Cell Infusion | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | CD34 Positive Stem Cell Infusion | Cell therapy | 4e+06 cells/kg | Intravenous |